References
- Reichart D, Magnussen C, Zeller T, Blankenberg S. Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literature. J Intern Med. 2019;286(4):362–372. doi:10.1111/joim.12944
- Garfinkel AC, Seidman JG, Seidman CE. Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy. Heart Fail Clin. 2018; 14(2):139–146. doi:10.1016/j.hfc.2017.12.004
- Stöhr EJ, Takayama H, Ferrari G. Stretch your heart—but not too far: The role of titin mutations in dilated cardiomyopathy. J Thorac Cardiovasc Surg. 2018;156(1):209–214. doi:10.1016/j.jtcvs.2017.10.160
- Tharp CA, Haywood ME, Sbaizero O, Taylor MRG, Mestroni L. The Giant Protein Titin’s Role in Cardiomyopathy: Genetic, Transcriptional, and Post-translational Modifications of TTN and Their Contribution to Cardiac Disease. Front Physiol. 2019;10. doi:10.3389/fphys.2019.01436
- Augusto JB, Eiros R, Nakou E, Moura-Ferreira S, Treibel TA, Captur G, Akhtar MA, Protonotarios A, Gossios TD, Savvatis K, Syrris P, Mohiddin S, Moon JC, Elliott PM, Lopes LR. Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: A comprehensive genotype-imaging phenotype study. Eur Heart J Cardiovasc Imaging. 2020;21(3):326–336. doi:10.1093/ehjci/jez188.